Chronic eosinophilic leukemia presenting with mouth and penile ulcers.
Jose E
JE
Najera
Lucy
L
Harn
D000328:Adult; D000970:Antineoplastic Agents / Q000627:therapeutic use; D001549:Benzamides; D001856:Bone Marrow Examination; D002872:Chromosome Deletion; D025063:Chromosome Disorders / Q000175:diagnosis / Q000188:drug therapy / Q000235:genetics; D002894:Chromosomes, Human, Pair 4 / Q000235:genetics; D003937:Diagnosis, Differential; D004804:Eosinophils / Q000473:pathology; D050939:Gene Fusion; D006801:Humans; D017681:Hypereosinophilic Syndrome / Q000175:diagnosis* / Q000188:drug therapy / Q000235:genetics; D000068877:Imatinib Mesylate; D007958:Leukocyte Count; D008297:Male; D019226:Oral Ulcer / Q000188:drug therapy / Q000209:etiology* / Q000235:genetics; D010409:Penile Diseases / Q000188:drug therapy / Q000209:etiology* / Q000235:genetics; D010879:Piperazines / Q000627:therapeutic use; D011743:Pyrimidines / Q000627:therapeutic use; D020796:Receptor, Platelet-Derived Growth Factor alpha / Q000235:genetics; D014456:Ulcer / Q000188:drug therapy / Q000209:etiology* / Q000235:genetics; D039221:mRNA Cleavage and Polyadenylation Factors / Q000235:genetics
D000970:Antineoplastic Agents; D001549:Benzamides; C479818:FIP1L1 protein, human; D010879:Piperazines; D011743:Pyrimidines; D039221:mRNA Cleavage and Polyadenylation Factors; D000068877:Imatinib Mesylate; D020796:Receptor, Platelet-Derived Growth Factor alpha